Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025

Group 1 - Amarin Corporation will host a conference call on March 12, 2025, at 8:00 a.m. ET to discuss its fourth quarter and full year 2024 results [1] - The financial results will be released in the pre-market hours on the same day [1] - The call will include a Q&A session with the management team [1] Group 2 - Amarin is an innovative pharmaceutical company focused on cardiovascular disease management, with offices in multiple countries including the United States, Ireland, and Switzerland [3] - The company aims to enhance the scientific understanding of cardiovascular risks that persist beyond traditional therapies [3] Group 3 - Amarin provides various channels for investor communication, including its website and investor relations section, where material information is regularly posted [4] - The company encourages stakeholders to review the information available on these channels [4]